Valion Bio VBIO Cash Flow Statement (2021-2026)

NASDAQ VBIO
$0.12 -0.01 (-7.69%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-1.28M-1.23M-2.29M-2.56M-3.07M-2.63M-2.31M-2.17M-2.18M-1.81M-2.30M-1.53M-1.33M-1.43M-1.51M-1.51M-1.93M-2.48M0.07M-15.62M
Depreciation and Depletion (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.36M
Share-based Compensation (Quarter)
0.01M0.02M0.02M0.06M0.11M0.11M0.23M0.08M0.08M0.05M0.06M0.05M0.05M0.06M0.10M0.10M0.14M-0.32M0.13M
Asset Writedowns and Impairment (Quarter)
-0.03M-0.00M0.00M0.01M-0.01M0.34M
Change in Working Capital (Quarter)
0.00M
Change in Receivables (Quarter)
0.04M-0.00M-0.00M0.03M-0.00M-0.03M-0.04M0.12M0.02M-0.10M-0.05M-0.01M0.06M-0.06M0.01M
Change in Inventory (Quarter)
0.05M0.14M0.02M0.39M-0.07M0.10M0.08M0.04M-0.06M-0.14M0.01M0.01M-0.04M0.01M-0.01M-0.02M-0.05M-16.17M
Change in Account Payables (Quarter)
0.52M0.12M-0.51M-0.16M1.29M-0.31M-0.28M-0.23M-0.26M-0.19M0.07M-0.17M-0.10M-0.11M-0.21M0.31M-0.20M0.23M-0.20M
Change in Accured Expenses (Quarter)
-0.01M0.01M-0.04M0.04M-0.01M-0.03M0.12M-0.08M-0.15M0.04M0.29M-0.23M-0.12M0.08M-0.08M0.16M0.20M-0.33M0.21M
Other Working Capital Changes (Quarter)
-0.12M0.03M0.74M-0.17M-0.22M-0.07M0.45M0.06M-0.02M-0.05M0.10M-0.08M-0.06M0.10M0.02M0.09M-0.09M-0.02M
Cash from Operations (Quarter)
-0.54M-1.64M-2.76M-2.20M-1.70M-2.80M-2.22M-2.43M-2.47M-1.80M-1.81M-1.70M-1.25M-1.45M-0.68M-0.90M-1.80M-2.00M-2.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.18M1.14M0.13M
Amortization of Deferred Charges (Quarter)
0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.03M0.27M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.36M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.01M0.09M0.02M0.01M0.03M
Cash from Investing Activities (Quarter)
-0.01M-0.01M-0.09M-0.02M-0.53M-0.02M-0.01M-0.15M
Financing Activities
Other financing activities (Quarter)
0.06M0.11M
Cash from Financing Activities (Quarter)
1.57M0.87M14.89M-0.58M4.17M-0.04M4.38M-0.06M3.31M-0.10M1.18M0.08M2.36M4.27M11.63M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
4.19M4.32M-3.25M0.43M
Additional items
Change in Cash (Quarter)
1.02M-0.78M12.13M-2.17M-1.75M-2.72M-2.81M1.65M-2.51M2.51M-1.77M-1.73M2.02M-1.50M-0.19M-1.33M0.52M2.27M9.20M
Free Cash Flow (Quarter)
-0.54M-1.64M-2.76M-2.21M-1.70M-2.81M-2.22M-2.52M-2.50M-1.80M-1.81M-1.70M-1.25M-1.45M-0.68M-0.90M-1.80M-2.01M-2.33M
Net Cash Flow (Quarter)
1.02M-0.78M12.13M-2.21M-1.70M-2.81M-2.80M1.65M-2.54M2.58M-1.81M-1.76M2.06M-1.54M0.50M-1.34M0.54M2.26M9.18M